| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chemokine CXCL12 | 15 | 2021 | 51 | 3.930 |
Why?
|
| Osteogenesis | 17 | 2023 | 152 | 3.090 |
Why?
|
| Bone Marrow Cells | 16 | 2021 | 217 | 2.460 |
Why?
|
| Kynurenine | 8 | 2021 | 36 | 2.280 |
Why?
|
| Receptors, Aryl Hydrocarbon | 4 | 2022 | 46 | 1.650 |
Why?
|
| MicroRNAs | 9 | 2021 | 447 | 1.470 |
Why?
|
| Cell Differentiation | 27 | 2022 | 1034 | 1.400 |
Why?
|
| Autophagy | 6 | 2021 | 208 | 1.310 |
Why?
|
| Dipeptidyl Peptidase 4 | 2 | 2019 | 15 | 1.230 |
Why?
|
| Tryptophan | 9 | 2021 | 65 | 1.200 |
Why?
|
| Bone Morphogenetic Protein 2 | 5 | 2018 | 57 | 1.150 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 4 | 2017 | 63 | 1.150 |
Why?
|
| Bone Density | 4 | 2020 | 159 | 1.140 |
Why?
|
| Hip Fractures | 2 | 2017 | 26 | 1.120 |
Why?
|
| Signal Transduction | 18 | 2022 | 2689 | 1.110 |
Why?
|
| Body Composition | 2 | 2017 | 119 | 1.090 |
Why?
|
| Aging | 14 | 2022 | 911 | 1.050 |
Why?
|
| Animals | 66 | 2023 | 20881 | 0.900 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 58 | 0.890 |
Why?
|
| Cellular Senescence | 4 | 2021 | 112 | 0.870 |
Why?
|
| Mice | 43 | 2023 | 8474 | 0.780 |
Why?
|
| Mice, Inbred C57BL | 29 | 2023 | 2791 | 0.770 |
Why?
|
| Receptors, CXCR4 | 5 | 2019 | 48 | 0.740 |
Why?
|
| RANK Ligand | 1 | 2020 | 73 | 0.710 |
Why?
|
| Peptide Hormones | 1 | 2019 | 9 | 0.660 |
Why?
|
| Osteoporosis | 7 | 2021 | 88 | 0.650 |
Why?
|
| Leptin | 3 | 2015 | 80 | 0.640 |
Why?
|
| Stromal Cells | 5 | 2021 | 113 | 0.620 |
Why?
|
| Fracture Healing | 2 | 2015 | 29 | 0.610 |
Why?
|
| Bone and Bones | 7 | 2022 | 145 | 0.590 |
Why?
|
| Brain Ischemia | 6 | 2013 | 665 | 0.570 |
Why?
|
| Genome-Wide Association Study | 3 | 2015 | 240 | 0.560 |
Why?
|
| Osteoblasts | 2 | 2019 | 99 | 0.560 |
Why?
|
| Cytokines | 3 | 2021 | 866 | 0.550 |
Why?
|
| Alzheimer Disease | 13 | 2015 | 565 | 0.530 |
Why?
|
| Caloric Restriction | 2 | 2015 | 22 | 0.530 |
Why?
|
| Apoptosis | 8 | 2022 | 1641 | 0.500 |
Why?
|
| Bone Regeneration | 2 | 2014 | 20 | 0.490 |
Why?
|
| Whole-Body Irradiation | 1 | 2014 | 52 | 0.490 |
Why?
|
| Amyloid beta-Peptides | 5 | 2012 | 191 | 0.470 |
Why?
|
| Drug Implants | 1 | 2014 | 19 | 0.470 |
Why?
|
| Osteoclasts | 4 | 2022 | 132 | 0.470 |
Why?
|
| Guanylate Kinases | 1 | 2014 | 8 | 0.470 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2013 | 3 | 0.460 |
Why?
|
| Skull Fractures | 1 | 2014 | 17 | 0.460 |
Why?
|
| Intelligence | 1 | 2014 | 45 | 0.460 |
Why?
|
| Keratinocytes | 1 | 2013 | 68 | 0.440 |
Why?
|
| Male | 43 | 2022 | 37321 | 0.440 |
Why?
|
| Dermatitis | 1 | 2013 | 28 | 0.440 |
Why?
|
| Cognition | 2 | 2015 | 513 | 0.440 |
Why?
|
| Gene Expression Regulation | 6 | 2020 | 1293 | 0.440 |
Why?
|
| Genetic Enhancement | 1 | 2012 | 3 | 0.420 |
Why?
|
| Genetic Therapy | 1 | 2014 | 291 | 0.420 |
Why?
|
| Cell Proliferation | 10 | 2021 | 1174 | 0.420 |
Why?
|
| Neurons | 7 | 2004 | 881 | 0.410 |
Why?
|
| Neurofilament Proteins | 5 | 2004 | 20 | 0.400 |
Why?
|
| Amino Acids, Aromatic | 4 | 2015 | 7 | 0.400 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 266 | 0.390 |
Why?
|
| Peptide Fragments | 4 | 2012 | 483 | 0.390 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2011 | 35 | 0.380 |
Why?
|
| Sodium-Coupled Vitamin C Transporters | 3 | 2015 | 3 | 0.370 |
Why?
|
| Blood Specimen Collection | 1 | 2010 | 17 | 0.350 |
Why?
|
| Cells, Cultured | 13 | 2018 | 2673 | 0.350 |
Why?
|
| Lewy Bodies | 4 | 1997 | 7 | 0.350 |
Why?
|
| Humans | 47 | 2022 | 68618 | 0.350 |
Why?
|
| Reperfusion Injury | 3 | 2021 | 320 | 0.340 |
Why?
|
| Minocycline | 3 | 2023 | 61 | 0.320 |
Why?
|
| Skull | 3 | 2018 | 63 | 0.310 |
Why?
|
| Ascorbic Acid | 3 | 2018 | 45 | 0.310 |
Why?
|
| Oxidative Stress | 6 | 2019 | 718 | 0.310 |
Why?
|
| Aged, 80 and over | 8 | 2017 | 4848 | 0.310 |
Why?
|
| Hemoglobins | 3 | 2006 | 120 | 0.300 |
Why?
|
| Brain | 13 | 2015 | 2176 | 0.290 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2006 | 48 | 0.280 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2015 | 110 | 0.270 |
Why?
|
| Up-Regulation | 9 | 2022 | 682 | 0.270 |
Why?
|
| Stroke | 4 | 2013 | 2163 | 0.260 |
Why?
|
| Wound Healing | 3 | 2018 | 260 | 0.260 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 301 | 0.260 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2022 | 332 | 0.250 |
Why?
|
| Parkinson Disease | 6 | 1997 | 272 | 0.250 |
Why?
|
| Aged | 17 | 2022 | 14862 | 0.250 |
Why?
|
| Female | 26 | 2022 | 38074 | 0.250 |
Why?
|
| Substantia Nigra | 3 | 1997 | 102 | 0.250 |
Why?
|
| Estrogen Receptor Modulators | 2 | 2022 | 6 | 0.240 |
Why?
|
| DNA, Complementary | 1 | 2004 | 251 | 0.240 |
Why?
|
| Diet | 4 | 2021 | 514 | 0.230 |
Why?
|
| Calpain | 1 | 2004 | 205 | 0.230 |
Why?
|
| Immunohistochemistry | 10 | 2018 | 1174 | 0.220 |
Why?
|
| Muscle, Skeletal | 3 | 2015 | 396 | 0.220 |
Why?
|
| Sex Factors | 2 | 2017 | 1266 | 0.220 |
Why?
|
| Receptors, Immunologic | 3 | 2012 | 72 | 0.210 |
Why?
|
| Cardiovascular Diseases | 2 | 2022 | 940 | 0.210 |
Why?
|
| NF-kappa B | 3 | 2001 | 432 | 0.200 |
Why?
|
| Adiposity | 2 | 2020 | 88 | 0.200 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 627 | 0.200 |
Why?
|
| Ligands | 2 | 2022 | 317 | 0.200 |
Why?
|
| Bone Diseases | 1 | 2021 | 20 | 0.200 |
Why?
|
| Receptors, Nerve Growth Factor | 2 | 2021 | 20 | 0.200 |
Why?
|
| Muscular Diseases | 1 | 2021 | 41 | 0.190 |
Why?
|
| Lipid Metabolism | 1 | 2022 | 186 | 0.190 |
Why?
|
| Musculoskeletal Physiological Phenomena | 1 | 2021 | 6 | 0.190 |
Why?
|
| Infarction, Middle Cerebral Artery | 5 | 2012 | 105 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2014 | 1745 | 0.190 |
Why?
|
| Thrombolytic Therapy | 2 | 2013 | 233 | 0.190 |
Why?
|
| Receptors, Glutamate | 1 | 2020 | 22 | 0.190 |
Why?
|
| RAW 264.7 Cells | 1 | 2020 | 42 | 0.180 |
Why?
|
| NFATC Transcription Factors | 1 | 2020 | 40 | 0.180 |
Why?
|
| Retinal Vessels | 1 | 2021 | 74 | 0.180 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2020 | 114 | 0.180 |
Why?
|
| Bone Resorption | 2 | 2017 | 64 | 0.180 |
Why?
|
| beta-Galactosidase | 1 | 2019 | 88 | 0.170 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 2011 | 74 | 0.170 |
Why?
|
| Myostatin | 3 | 2015 | 9 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 122 | 0.170 |
Why?
|
| Muscles | 1 | 2019 | 158 | 0.160 |
Why?
|
| Adipogenesis | 2 | 2018 | 17 | 0.160 |
Why?
|
| Musculoskeletal System | 1 | 2018 | 11 | 0.160 |
Why?
|
| Disease Models, Animal | 8 | 2021 | 2550 | 0.160 |
Why?
|
| Proteolysis | 1 | 2019 | 97 | 0.160 |
Why?
|
| Sertraline | 1 | 2018 | 62 | 0.160 |
Why?
|
| Rats | 10 | 2015 | 5300 | 0.150 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 1536 | 0.150 |
Why?
|
| Bone Remodeling | 1 | 2018 | 45 | 0.150 |
Why?
|
| Sarcopenia | 2 | 2019 | 9 | 0.150 |
Why?
|
| Inflammation | 2 | 2021 | 1030 | 0.150 |
Why?
|
| Amino Acids | 1 | 2018 | 131 | 0.150 |
Why?
|
| Busulfan | 1 | 2017 | 13 | 0.150 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2017 | 3 | 0.150 |
Why?
|
| Receptors, Leptin | 2 | 2015 | 6 | 0.150 |
Why?
|
| Extracellular Vesicles | 1 | 2017 | 21 | 0.140 |
Why?
|
| Tyrosine | 2 | 2015 | 196 | 0.140 |
Why?
|
| Cyclophosphamide | 1 | 2017 | 129 | 0.140 |
Why?
|
| Follistatin | 2 | 2015 | 5 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2018 | 507 | 0.140 |
Why?
|
| Myocardial Infarction | 2 | 2013 | 807 | 0.140 |
Why?
|
| Endothelium, Vascular | 3 | 2004 | 371 | 0.130 |
Why?
|
| Heme Oxygenase-1 | 2 | 2017 | 40 | 0.130 |
Why?
|
| Diet, Protein-Restricted | 1 | 2015 | 4 | 0.130 |
Why?
|
| Biological Assay | 1 | 2016 | 88 | 0.130 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2015 | 16 | 0.130 |
Why?
|
| HMGN1 Protein | 1 | 2015 | 1 | 0.130 |
Why?
|
| Anabolic Agents | 1 | 2015 | 6 | 0.130 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 89 | 0.130 |
Why?
|
| Chemokines, CXC | 2 | 2005 | 16 | 0.120 |
Why?
|
| Leukoencephalopathies | 1 | 2015 | 13 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2011 | 1664 | 0.120 |
Why?
|
| Liver | 2 | 2023 | 1118 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2014 | 2083 | 0.120 |
Why?
|
| Transfection | 2 | 2017 | 782 | 0.120 |
Why?
|
| Intermediate Filament Proteins | 2 | 1991 | 12 | 0.120 |
Why?
|
| Hypoxia-Ischemia, Brain | 2 | 2005 | 56 | 0.120 |
Why?
|
| Caspases | 3 | 2011 | 194 | 0.120 |
Why?
|
| Down-Regulation | 5 | 2019 | 447 | 0.120 |
Why?
|
| Phenylalanine | 1 | 2014 | 22 | 0.120 |
Why?
|
| Bone Transplantation | 1 | 2014 | 43 | 0.120 |
Why?
|
| Middle Aged | 11 | 2015 | 21147 | 0.120 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2015 | 118 | 0.120 |
Why?
|
| Phenotype | 2 | 2015 | 947 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 3 | 2004 | 149 | 0.120 |
Why?
|
| Tibia | 1 | 2014 | 93 | 0.120 |
Why?
|
| Cell Survival | 2 | 2015 | 901 | 0.110 |
Why?
|
| Models, Biological | 1 | 2018 | 981 | 0.110 |
Why?
|
| Myoblasts | 1 | 2013 | 22 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 1054 | 0.110 |
Why?
|
| Muscular Atrophy | 1 | 2013 | 35 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2015 | 567 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2014 | 304 | 0.110 |
Why?
|
| Cell Transplantation | 1 | 2013 | 22 | 0.110 |
Why?
|
| Activins | 1 | 2012 | 4 | 0.110 |
Why?
|
| Cell Movement | 3 | 2021 | 630 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 5 | 2021 | 200 | 0.110 |
Why?
|
| Myoblasts, Skeletal | 1 | 2012 | 5 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2014 | 220 | 0.110 |
Why?
|
| Doxycycline | 1 | 2013 | 49 | 0.110 |
Why?
|
| Incidence | 1 | 2017 | 1603 | 0.110 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2013 | 86 | 0.100 |
Why?
|
| Gait | 1 | 2013 | 120 | 0.100 |
Why?
|
| Ischemic Preconditioning | 1 | 2012 | 31 | 0.100 |
Why?
|
| Alzheimer Vaccines | 1 | 2012 | 1 | 0.100 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 168 | 0.100 |
Why?
|
| Time Factors | 8 | 2015 | 4655 | 0.100 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2018 | 209 | 0.100 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 290 | 0.100 |
Why?
|
| Oxygen | 1 | 2014 | 386 | 0.100 |
Why?
|
| White Matter | 1 | 2015 | 174 | 0.100 |
Why?
|
| Calcification, Physiologic | 3 | 2017 | 31 | 0.100 |
Why?
|
| Extracellular Matrix | 1 | 2015 | 493 | 0.100 |
Why?
|
| Swine | 1 | 2013 | 672 | 0.100 |
Why?
|
| Microglia | 3 | 2004 | 143 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2015 | 342 | 0.100 |
Why?
|
| Hippocampus | 3 | 2005 | 471 | 0.100 |
Why?
|
| Proteomics | 1 | 2014 | 246 | 0.100 |
Why?
|
| Organelles | 1 | 1991 | 18 | 0.100 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 1070 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 786 | 0.100 |
Why?
|
| Macaca mulatta | 2 | 2012 | 77 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2015 | 2358 | 0.100 |
Why?
|
| Rhabdomyolysis | 1 | 2011 | 16 | 0.100 |
Why?
|
| Antigen-Antibody Complex | 1 | 2012 | 175 | 0.090 |
Why?
|
| Neoplasms | 1 | 2022 | 1667 | 0.090 |
Why?
|
| Diabetes Mellitus | 1 | 2017 | 694 | 0.090 |
Why?
|
| Emergency Medical Services | 1 | 2013 | 225 | 0.090 |
Why?
|
| Epigenesis, Genetic | 2 | 2022 | 163 | 0.090 |
Why?
|
| Laboratory Animal Science | 1 | 2010 | 8 | 0.090 |
Why?
|
| Stem Cells | 4 | 2019 | 248 | 0.090 |
Why?
|
| Cathepsins | 1 | 2010 | 37 | 0.090 |
Why?
|
| Boronic Acids | 1 | 2010 | 40 | 0.090 |
Why?
|
| Pyrazines | 1 | 2010 | 46 | 0.090 |
Why?
|
| Body Weight | 3 | 2017 | 554 | 0.090 |
Why?
|
| Risk Factors | 2 | 2017 | 5731 | 0.090 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2012 | 296 | 0.090 |
Why?
|
| Cultural Diversity | 1 | 2010 | 67 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2017 | 7029 | 0.080 |
Why?
|
| Immunoglobulin G | 3 | 2012 | 481 | 0.080 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 148 | 0.080 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 1851 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 742 | 0.080 |
Why?
|
| Gastric Inhibitory Polypeptide | 1 | 2008 | 6 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2011 | 232 | 0.080 |
Why?
|
| Femur | 1 | 2008 | 113 | 0.080 |
Why?
|
| X-Ray Microtomography | 2 | 2018 | 50 | 0.080 |
Why?
|
| Cloning, Molecular | 2 | 2006 | 357 | 0.080 |
Why?
|
| Benzimidazoles | 2 | 2006 | 128 | 0.080 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2006 | 8 | 0.070 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2006 | 12 | 0.070 |
Why?
|
| Apolipoprotein E4 | 1 | 2006 | 31 | 0.070 |
Why?
|
| Mice, Transgenic | 5 | 2012 | 1033 | 0.070 |
Why?
|
| Surface Plasmon Resonance | 1 | 2006 | 50 | 0.070 |
Why?
|
| Rats, Wistar | 4 | 2015 | 371 | 0.070 |
Why?
|
| Cattle | 2 | 2004 | 475 | 0.070 |
Why?
|
| In Vitro Techniques | 3 | 2015 | 765 | 0.070 |
Why?
|
| United States | 2 | 2017 | 7367 | 0.070 |
Why?
|
| Family Health | 1 | 2006 | 83 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2006 | 1083 | 0.070 |
Why?
|
| Glucose | 1 | 2008 | 307 | 0.070 |
Why?
|
| Brain Damage, Chronic | 1 | 2006 | 25 | 0.070 |
Why?
|
| Brain Infarction | 2 | 2006 | 54 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 498 | 0.070 |
Why?
|
| Astrocytes | 2 | 2005 | 270 | 0.070 |
Why?
|
| Protein Binding | 2 | 2006 | 1027 | 0.070 |
Why?
|
| Bromodeoxyuridine | 1 | 2005 | 37 | 0.060 |
Why?
|
| Tetrazoles | 1 | 2006 | 160 | 0.060 |
Why?
|
| Epitope Mapping | 1 | 2004 | 10 | 0.060 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 271 | 0.060 |
Why?
|
| Sequence Analysis, Protein | 1 | 2004 | 16 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 272 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 710 | 0.060 |
Why?
|
| Myogenin | 2 | 2015 | 9 | 0.060 |
Why?
|
| MyoD Protein | 2 | 2015 | 13 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 2 | 2002 | 164 | 0.060 |
Why?
|
| Encephalitis | 1 | 2004 | 43 | 0.060 |
Why?
|
| Hypertension | 2 | 2006 | 1535 | 0.060 |
Why?
|
| Hematopoiesis | 1 | 2004 | 108 | 0.060 |
Why?
|
| Antibodies | 1 | 2004 | 241 | 0.060 |
Why?
|
| Chickens | 1 | 2004 | 232 | 0.060 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 328 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 174 | 0.060 |
Why?
|
| Ischemia | 2 | 2004 | 229 | 0.060 |
Why?
|
| Cerebral Infarction | 1 | 2004 | 103 | 0.060 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2022 | 11 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 19 | 0.050 |
Why?
|
| Receptor for Advanced Glycation End Products | 3 | 2012 | 19 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2015 | 247 | 0.050 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 186 | 0.050 |
Why?
|
| Ischemic Attack, Transient | 1 | 2004 | 167 | 0.050 |
Why?
|
| Ornithine | 1 | 2022 | 9 | 0.050 |
Why?
|
| Nerve Degeneration | 2 | 2001 | 134 | 0.050 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2002 | 30 | 0.050 |
Why?
|
| Clozapine | 1 | 2002 | 46 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2022 | 150 | 0.050 |
Why?
|
| Cerebral Hemorrhage | 1 | 2004 | 198 | 0.050 |
Why?
|
| Haloperidol | 1 | 2002 | 95 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2004 | 268 | 0.050 |
Why?
|
| Risperidone | 1 | 2002 | 48 | 0.050 |
Why?
|
| Epigenomics | 1 | 2022 | 29 | 0.050 |
Why?
|
| Maze Learning | 1 | 2002 | 138 | 0.050 |
Why?
|
| Glycation End Products, Advanced | 1 | 2003 | 125 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2002 | 58 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2011 | 2223 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2006 | 498 | 0.050 |
Why?
|
| Neuropil | 1 | 2001 | 6 | 0.050 |
Why?
|
| Neurofibrillary Tangles | 1 | 2001 | 8 | 0.050 |
Why?
|
| Plaque, Amyloid | 1 | 2001 | 31 | 0.050 |
Why?
|
| Endothelial Cells | 2 | 2021 | 384 | 0.050 |
Why?
|
| Adult | 5 | 2018 | 21403 | 0.050 |
Why?
|
| Biodiversity | 1 | 2021 | 16 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 317 | 0.050 |
Why?
|
| Thiocarbamates | 1 | 2001 | 20 | 0.050 |
Why?
|
| Cyclic N-Oxides | 1 | 2001 | 17 | 0.050 |
Why?
|
| Intravitreal Injections | 1 | 2021 | 16 | 0.050 |
Why?
|
| ErbB Receptors | 1 | 2022 | 239 | 0.050 |
Why?
|
| Pyramidal Cells | 1 | 2001 | 79 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2021 | 19 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2021 | 78 | 0.050 |
Why?
|
| Proline | 1 | 2001 | 52 | 0.050 |
Why?
|
| Nephritis | 1 | 2001 | 37 | 0.050 |
Why?
|
| Feces | 1 | 2021 | 88 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2021 | 54 | 0.050 |
Why?
|
| Endothelium | 1 | 2021 | 98 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2021 | 147 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2022 | 193 | 0.050 |
Why?
|
| Capillaries | 1 | 2021 | 105 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2021 | 137 | 0.050 |
Why?
|
| Phylogeny | 1 | 2021 | 197 | 0.040 |
Why?
|
| Picolinic Acids | 1 | 2020 | 4 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2000 | 52 | 0.040 |
Why?
|
| Phosphorylation | 2 | 2013 | 1200 | 0.040 |
Why?
|
| Epitopes | 3 | 2004 | 146 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2021 | 235 | 0.040 |
Why?
|
| Bacteria | 1 | 2021 | 193 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2021 | 219 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2021 | 183 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 2 | 2023 | 1026 | 0.040 |
Why?
|
| Luminescent Proteins | 3 | 2004 | 57 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2020 | 168 | 0.040 |
Why?
|
| Age Factors | 2 | 2019 | 1864 | 0.040 |
Why?
|
| Mitochondria | 1 | 2004 | 643 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 201 | 0.040 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 99 | 0.040 |
Why?
|
| Gene Targeting | 1 | 2018 | 58 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2000 | 244 | 0.040 |
Why?
|
| Cell Hypoxia | 2 | 2014 | 92 | 0.040 |
Why?
|
| Antioxidants | 1 | 2001 | 304 | 0.040 |
Why?
|
| Young Adult | 1 | 2010 | 5717 | 0.040 |
Why?
|
| Functional Laterality | 2 | 2013 | 240 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 320 | 0.040 |
Why?
|
| Adult Stem Cells | 1 | 2018 | 13 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 55 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 31 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2018 | 134 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2011 | 160 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 3 | 2004 | 261 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2018 | 63 | 0.040 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 10 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 189 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2019 | 295 | 0.040 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 191 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2018 | 219 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 442 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2015 | 114 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 532 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2010 | 137 | 0.040 |
Why?
|
| Phagocytosis | 1 | 1997 | 65 | 0.040 |
Why?
|
| Endocytosis | 1 | 2017 | 113 | 0.030 |
Why?
|
| Biomarkers | 1 | 2022 | 1593 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2021 | 1692 | 0.030 |
Why?
|
| Computational Biology | 1 | 2018 | 190 | 0.030 |
Why?
|
| Fetus | 2 | 1995 | 157 | 0.030 |
Why?
|
| Cell Death | 2 | 2010 | 329 | 0.030 |
Why?
|
| Growth Hormone | 1 | 2015 | 51 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2015 | 12 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2015 | 12 | 0.030 |
Why?
|
| Oxidants | 1 | 2015 | 48 | 0.030 |
Why?
|
| Scotland | 1 | 2015 | 18 | 0.030 |
Why?
|
| Protein Precursors | 1 | 1995 | 105 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2010 | 852 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2015 | 69 | 0.030 |
Why?
|
| Myosin Heavy Chains | 1 | 2015 | 49 | 0.030 |
Why?
|
| Amyloid | 1 | 1995 | 39 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 2015 | 95 | 0.030 |
Why?
|
| Longevity | 1 | 2015 | 60 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2015 | 56 | 0.030 |
Why?
|
| Nasal Mucosa | 1 | 1995 | 68 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2001 | 689 | 0.030 |
Why?
|
| Causality | 1 | 2015 | 82 | 0.030 |
Why?
|
| Eating | 1 | 2015 | 119 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2005 | 396 | 0.030 |
Why?
|
| Down Syndrome | 1 | 1995 | 120 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 214 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2015 | 221 | 0.030 |
Why?
|
| Nova Scotia | 1 | 2013 | 1 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 126 | 0.030 |
Why?
|
| Paracrine Communication | 1 | 2013 | 31 | 0.030 |
Why?
|
| Nervous System Diseases | 2 | 1991 | 142 | 0.030 |
Why?
|
| Radiation Chimera | 2 | 2004 | 15 | 0.030 |
Why?
|
| Olfactory Pathways | 1 | 1993 | 9 | 0.030 |
Why?
|
| Digoxigenin | 1 | 1993 | 2 | 0.030 |
Why?
|
| Uridine Triphosphate | 1 | 1993 | 4 | 0.030 |
Why?
|
| Kidney | 2 | 2011 | 945 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2004 | 337 | 0.030 |
Why?
|
| Dementia | 1 | 2015 | 158 | 0.030 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2012 | 5 | 0.030 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 2012 | 7 | 0.030 |
Why?
|
| Melanins | 1 | 1993 | 24 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 196 | 0.030 |
Why?
|
| Histocytochemistry | 1 | 1993 | 149 | 0.030 |
Why?
|
| tau Proteins | 1 | 1993 | 61 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2013 | 246 | 0.030 |
Why?
|
| Atherosclerosis | 1 | 2015 | 204 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2013 | 324 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2015 | 517 | 0.030 |
Why?
|
| Administration, Intravenous | 1 | 2012 | 89 | 0.030 |
Why?
|
| Peptides | 1 | 2015 | 455 | 0.030 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 168 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 706 | 0.030 |
Why?
|
| Binding Sites | 2 | 2004 | 631 | 0.030 |
Why?
|
| Spinal Cord | 1 | 1993 | 244 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 1992 | 115 | 0.020 |
Why?
|
| alpha-MSH | 1 | 1991 | 7 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2014 | 332 | 0.020 |
Why?
|
| Olfactory Mucosa | 1 | 1991 | 11 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 1991 | 10 | 0.020 |
Why?
|
| Cerebral Cortex | 2 | 1992 | 415 | 0.020 |
Why?
|
| Hemin | 1 | 2011 | 10 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 1991 | 22 | 0.020 |
Why?
|
| Models, Animal | 1 | 2012 | 252 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1991 | 122 | 0.020 |
Why?
|
| Chimera | 1 | 2011 | 33 | 0.020 |
Why?
|
| Survival | 1 | 2011 | 22 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 2011 | 119 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2011 | 81 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2011 | 114 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2006 | 282 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2004 | 511 | 0.020 |
Why?
|
| Kidney Tubules | 1 | 2011 | 80 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 331 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 1752 | 0.020 |
Why?
|
| Metabolism | 1 | 2010 | 12 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 951 | 0.020 |
Why?
|
| Bortezomib | 1 | 2010 | 45 | 0.020 |
Why?
|
| Internationality | 1 | 2010 | 74 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 109 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 191 | 0.020 |
Why?
|
| Research Personnel | 1 | 2010 | 83 | 0.020 |
Why?
|
| Attitude | 1 | 2010 | 121 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2010 | 142 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2012 | 377 | 0.020 |
Why?
|
| Language | 1 | 2010 | 120 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 954 | 0.020 |
Why?
|
| Elasticity | 1 | 2008 | 103 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2010 | 215 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2008 | 208 | 0.020 |
Why?
|
| Fractures, Bone | 1 | 2008 | 132 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2008 | 146 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2006 | 1451 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 2008 | 368 | 0.020 |
Why?
|
| Communication | 1 | 2010 | 329 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2004 | 431 | 0.020 |
Why?
|
| Obesity | 1 | 2013 | 1076 | 0.020 |
Why?
|
| Brain Edema | 1 | 2006 | 50 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2005 | 38 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2006 | 184 | 0.020 |
Why?
|
| Cell Count | 1 | 2005 | 248 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2004 | 71 | 0.020 |
Why?
|
| Plant Lectins | 1 | 2004 | 20 | 0.010 |
Why?
|
| Carbocyanines | 1 | 2004 | 13 | 0.010 |
Why?
|
| Sodium Azide | 1 | 2004 | 4 | 0.010 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2004 | 4 | 0.010 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2004 | 29 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2004 | 23 | 0.010 |
Why?
|
| Staurosporine | 1 | 2004 | 19 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2004 | 18 | 0.010 |
Why?
|
| Leukocytes | 1 | 2004 | 99 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 1447 | 0.010 |
Why?
|
| von Willebrand Factor | 1 | 2004 | 47 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2004 | 48 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 88 | 0.010 |
Why?
|
| Microtomy | 1 | 2004 | 11 | 0.010 |
Why?
|
| Neocortex | 1 | 2004 | 17 | 0.010 |
Why?
|
| Antigens | 1 | 2004 | 90 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2004 | 36 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 92 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2004 | 35 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 2004 | 107 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2004 | 111 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 123 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2004 | 215 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2006 | 470 | 0.010 |
Why?
|
| Cisplatin | 1 | 2004 | 192 | 0.010 |
Why?
|
| Hypoxia | 1 | 2004 | 169 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 489 | 0.010 |
Why?
|
| Spatial Behavior | 1 | 2002 | 18 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 2002 | 27 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2004 | 791 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2002 | 49 | 0.010 |
Why?
|
| Cerebrovascular Circulation | 1 | 2004 | 296 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2003 | 228 | 0.010 |
Why?
|
| Fourier Analysis | 1 | 2001 | 31 | 0.010 |
Why?
|
| Cell Size | 1 | 2001 | 76 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2004 | 245 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 411 | 0.010 |
Why?
|
| Mineralocorticoids | 1 | 2001 | 9 | 0.010 |
Why?
|
| Spin Labels | 1 | 2001 | 27 | 0.010 |
Why?
|
| Desoxycorticosterone | 1 | 2001 | 41 | 0.010 |
Why?
|
| Microscopy, Electron | 2 | 1991 | 351 | 0.010 |
Why?
|
| Neuronal Plasticity | 1 | 2004 | 274 | 0.010 |
Why?
|
| Superoxides | 1 | 2001 | 70 | 0.010 |
Why?
|
| Autoimmunity | 1 | 2001 | 118 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2004 | 1465 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2001 | 329 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 617 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 1753 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 465 | 0.010 |
Why?
|
| Aorta | 1 | 2001 | 316 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2004 | 2077 | 0.010 |
Why?
|
| Patient Selection | 1 | 2001 | 592 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 1995 | 2455 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 626 | 0.010 |
Why?
|
| Infant | 2 | 1995 | 2891 | 0.010 |
Why?
|
| Prions | 1 | 1995 | 4 | 0.010 |
Why?
|
| Prion Proteins | 1 | 1995 | 4 | 0.010 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 1991 | 14 | 0.010 |
Why?
|
| Neurites | 1 | 1991 | 18 | 0.010 |
Why?
|
| Keratins | 1 | 1991 | 48 | 0.010 |
Why?
|
| Vimentin | 1 | 1991 | 47 | 0.010 |
Why?
|
| Epithelium | 1 | 1991 | 172 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1995 | 1553 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1991 | 75 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 1991 | 248 | 0.010 |
Why?
|
| Reference Values | 1 | 1991 | 579 | 0.010 |
Why?
|
| Infant, Premature | 1 | 1991 | 284 | 0.010 |
Why?
|